Considering the potential influence of DM and DR on CC flow in AMD eyes, we aimed to assess whether the presence of diabetes and DR could affect the distribution of CC flow surrounding type 1 MNV before and after anti-VEGF therapy loading phase. This evidence concerns the gene VEGFA and age-related macular degeneration.